Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 14.8.2023 | EN | Official Journal of the European Union | C 286/27 |

---

Judgment of the General Court of 28 June 2023 — UGA Nutraceuticals v EUIPO — BASF (OMEGOR VITALITY)

(Case T-496/22) [(1)](#ntr1-C_2023286EN.01002701-E0001)

(EU trade mark - Opposition proceedings - Application for the EU word mark OMEGOR VITALITY - Earlier EU figurative mark OMACOR - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009 (now Article 8(1)(b) of Regulation (EU) 2017/1001))

(2023/C 286/36)

Language of the case: English

Parties

Applicant: UGA Nutraceuticals Srl (Gubbio, Italy) (represented by: M. Riva, J. Graffer and A. Ottolini, lawyers)

Defendant: European Union Intellectual Property Office (represented by: M. Chylińska and T. Frydendahl, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: BASF AS (Oslo, Norway)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 10 June 2022 (Case R 1200/2021-4).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders UGA Nutraceuticals Srl and the European Union Intellectual Property Office (EUIPO) to bear their own costs. |

---

---

[Top](#document1)